Tag archives

tuberculosis

Source:  The Lancet

“COVID-19 has the potential to cause substantial disruptions to health services, due to cases overburdening the health system or response measures limiting usual programmatic activities. We aimed to quantify the extent to which disruptions to services for HIV, tuberculosis, and malaria in low-income and middle-income countries with high burdens of these diseases could lead to additional loss of life over the next 5 years.”


This entry was posted in and tagged , , , on by .

Publisher:  GCTA

“The concept of a human rights-based response to tuberculosis (TB) is relatively new. The century-old, medicalized approach to TB did not consider the rights of the individual in planning the response. . . . With this Brief, we hope that policymakers, national TB program implementers, and communities affected by TB can come together to plan and implement interventions that uphold the dignity and human rights of all people affected by TB.”

 


This entry was posted in and tagged , on by .

Our friends at Results UK are following up, today on World TB day, on their recent webinars on including people-centred social support interventions in the Global Fund Allocation Cycle 2020-2022.

For further background listen to these webinars:
https://drive.google.com/file/d/1hTfnktORVMBBzlna2m9VV7Abc-kPkGGx/view


https://drive.google.com/file/d/1UAJ2KhnbenkJEFN9EPRTRCgzEatRFdaW/view

They are reaching out with a couple of resources that might be useful for contacting CCMs about the national funding requests, including a template letter. The ask is that you participate in this action THIS WEEK and share your action via this  tracker .

Steps to Supporting this Campaign:

Who to contact:

Country Coordinating Mechanisms (see below for how).  Consultants writing the funding requests.  Global Fund programme...
This entry was posted in Blog and tagged , on by .

Please find below a number of resources you can use for World TB Day. Included in the resources are a statement from GFAN Speaker Timur Abdullaev, links to Stop TB Resources, links to resources about COVID-19 and TB, and some social media tools.

Please note that given the current Global COVID-19 crisis, the language used below may be changed or adapted if needed.

Statement from GFAN Speaker Timur Abdullaev on World TB Day:

The world today is grappling with the COVID-19 pandemic that is testing the limits of our global health infrastructure.  As the world comes to grip with this pandemic and the resulting ramifications, it is important to not lose sight of the three epidemics and the global fight that impacts the lives of millions of people around the world each and every day – and has for decades and generations. 

Today on World TB Day, lets take a look at the impact of TB, a disease that ...


This entry was posted in Blog and tagged , on by .

Publisher:  Treatment Action Group (TAG)

“Tuberculosis (TB) is the number one killer of people living with HIV/AIDS, causing one in three of all AIDS-related deaths. Yet, unlike HIV, TB is curable: each one of these 250,000 deaths annually is preventable. All people living with HIV should be screened for TB, yet many countries do not report screening for TB in this vulnerable population.”

 

 

 


This entry was posted in and tagged , , on by .

Publisher: Policy Cures Research

The 2019 G-FINDER Report:  “[This] project has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development (R&D) of new products to prevent, diagnose, control or cure neglected diseases in developing countries. It provides an up-to-date analysis of how R&D investments are being allocated across diseases and product types, funding trends over time, and where the potential gaps lie. This is the twelfth annual G-FINDER report, providing new data on investments made in financial
year 2018. In all, 262 organisations completed the survey for FY2018, which covered 36 neglected diseases and all relevant product types – drugs, vaccines, biologics, diagnostics, microbicides and vector control products (chemical and biological control agents, and reservoir targeted vaccines) – as well as basic research.”


This entry was posted in and tagged , , , on by .